Bydureon Trademark Details

Bydureon was registered on Tuesday, July 3, 2012 and is currently owned by Amylin Pharmaceuticals, LLC under the registration number 4169150 . This mark is alive with a status of Registered. The last case file activity for this mark occured 11 years ago on Tuesday, July 3, 2012, according to the United State Patent & Trademark Office
Word Mark Bydureon
Status Alive Registered 700 — Registered

Current Owner

Amylin Pharmaceuticals, LLC of San Diego, CA

View all trademarks for Amylin Pharmaceuticals, LLC
Other Trademarks for Amylin Pharmaceuticals, LLC

Previous Owners

Amylin Pharmaceuticals, Inc. of San Diego, CA

View all trademarks for Amylin Pharmaceuticals, Inc.
Other Trademarks for Amylin Pharmaceuticals, Inc.
Serial Number 85329947
Registration Number 4169150
Status Date Tuesday, July 3, 2012
Filing Date Tuesday, July 3, 2012
Registration Date Tuesday, July 3, 2012
Attorney Marc Stanislawczyk

Correspondent

Marc Stanislawczyk
AstraZeneca Pharmaceuticals LP
FOP3-022
1800 Concord Pike
Wilmington DE 19850-5437

Case File Statements

Goods & Services Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, and diabetes
Pseudo Mark by Dureon

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, June 2, 2011
First Use Anywhere Wednesday, February 8, 2012
First Use In Commerce Wednesday, February 8, 2012
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.